Truxima (rituximab-abbs) Injection, 10 mg/mL, 50 mL Single-Dose Vial
Truxima is a biosimilar to rituximab, a CD20-directed cytolytic antibody, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 500 mg of rituximab-abbs in 50 mL at a concentration of 10 mg/mL. It is indicated for the treatment of certain B-cell non-Hodgkin's lymphomas and other conditions as prescribed.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Truxima is a biosimilar to rituximab, a CD20-directed cytolytic antibody, supplied as a sterile, preservative-free solution for intravenous infusion. Each single-dose vial contains 500 mg of rituximab-abbs in 50 mL at a concentration of 10 mg/mL. It is indicated for the treatment of certain B-cell non-Hodgkin's lymphomas and other conditions as prescribed.
1 vendor
